Clinical Trial Update: Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Travoprost ophthalmic solution 0.004% to Timolol 0.5% or 0.25% in pediatric glaucoma was completed, with results posted on 2015-04-13.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Timolol (timolol)
• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Pediatric Glaucoma, Elevated IOP in Pediatric Patients | Phase 3 | Status: COMPLETED | Results posted: 2015-04-13